作者:Yu. N. Klimochkin、M. V. Leonova、I. R. Korzhev、I. K. Moiseev、G. V. Vladyko、L. V. Korobchenko、E. I. Boreko、S. N. Nikolaeva
DOI:10.1007/bf00777145
日期:1992.7
Previous authors [i] have established the fact that introducing hydroxyl groups into the adamantane framework broadens the scope of antiviral activity as well as reduces toxicity. For example, 3,5-dimethyl-7-ethyladamantanol-i exhibits pronounced activity with respect to herpes, influenza and vaccine viruses [2]. It might be expected that changing the lipophilic capacity of the skeletal fragment when
以前的作者 [i] 已经确定将羟基引入金刚烷骨架扩大了抗病毒活性的范围并降低了毒性的事实。例如,3,5-二甲基-7-乙基金刚烷醇-i 对疱疹病毒、流感病毒和疫苗病毒具有显着的活性 [2]。可以预期,当分子中存在极性羟基时,改变骨架片段的亲脂能力将揭示结构与抑制病毒传播能力之间的联系,尤其是金刚烷系列制剂的抗病毒活性机制尚未确定。完全确定。